Etanercept helps restore normal growth in children with juvenile arthritis

Researchers from the Cincinnati Children's Hospital Medical Centre observed a statistically significant increase in mean height, weight, and body mass index (BMI) percentiles in patients with juvenile idiopathic arthritis (JIA) who were treated with etanercept or etanercept plus methotrexate (MTX). JIA patients treated with MTX alone did not display an increase in growth percentiles. Results of the 3-year study are available online and in the November issue of Arthritis and Rheumatism, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology...

Read the whole article on

More from